Medical Wipe Manufacturing and Formulation

The contract calls for the manufacturing and formulation of pre-moistened wipes designed specifically for use with medical electrodes, with strict requirements for conductivity enhancement to ensure optimal signal transmission during clinical procedures. All products must meet FDA compliance standards and be certified biocompatible to ensure patient safety, adhering to rigorous quality and sterility controls throughout production. The wipes are intended for use in surgical and diagnostic environments where consistent electrical performance and skin compatibility are critical, requiring precise ingredient selection and controlled manufacturing processes to maintain functional and regulatory integrity. This is a subcontract under the Department of Defense’s Medical Supply Chain initiative, with the place of performance designated at Keesler AFB, Mississippi, 39534-2519. The opportunity is posted under NAICS code 325620, which classifies it within pharmaceutical and medicinal product manufacturing. The solicitation was issued on July 19, 2026, with responses due by July 27, 2026, and is accessible via the DIBBS portal. While no set-aside provisions are specified, bidders must demonstrate capacity to meet the technical, regulatory, and logistical demands of supplying a defense medical supply chain, including adherence to defense-specific quality assurance protocols and timely delivery timelines.